Verano Holdings (VRNO) EBITDA Margin (2021 - 2026)
Verano Holdings' (VRNO) quarterly EBITDA Margin came in at 6.29% in Q1 2026, down 86.0% year-on-year from 44.94% in Q1 2025, and up 108.25% on a QoQ basis from 76.27% in Q4 2025.
Verano Holdings (VRNO) EBITDA Margin (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of EBITDA Margin data on file, last reported at 6.29% in Q1 2026.
- On a quarterly basis, EBITDA Margin fell 86.0% year-over-year to 6.29% in Q1 2026; TTM through Mar 2026 was 13.29%, a 1494.0% increase from a year earlier, with the FY2025 full-year figure at 13.04%, up 1396.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 6.29%, up from 76.27% in the prior quarter.
- Over the last five years, EBITDA Margin for VRNO reached as high as 2654.68% in Q1 2024 and fell as low as 139.26% in Q4 2024.
- Historically, EBITDA Margin has averaged 144.17% across 5 years, with a median of 7.15% in 2025.
- Across the five-year window, EBITDA Margin jumped 263981 bps in 2024 and plunged 264753 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 91.61% in 2022, then jumped by 91 bps to 8.31% in 2023, then slumped by 1576 bps to 139.26% in 2024, then soared by 45 bps to 76.27% in 2025, then soared by 108 bps to 6.29% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 6.29% in Q1 2026, 76.27% in Q4 2025, and 4.57% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 6.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.29% |
| Dec 31, 2025 | -76.27% |
| Sep 30, 2025 | 4.57% |
| Jun 30, 2025 | 12.96% |
| Mar 31, 2025 | 7.15% |
| Dec 31, 2024 | -139.26% |
| Sep 30, 2024 | 7.74% |
| Jun 30, 2024 | 12.26% |
| Mar 31, 2024 | 2,654.68% |
| Dec 31, 2023 | -8.31% |
| Sep 30, 2023 | 16.78% |
| Jun 30, 2023 | 13.00% |
| Mar 31, 2023 | 14.88% |
| Dec 31, 2022 | -91.61% |
| Sep 30, 2022 | 16.29% |
| Jun 30, 2022 | -1.02% |
| Mar 31, 2022 | 0.81% |
| Dec 31, 2021 | 13.92% |
| Sep 30, 2021 | 11.15% |
| Jun 30, 2021 | -0.08% |